Education on approval process may increase acceptance of new RSV vaccines
Aug 14, 2023
Just 13% of respondents knew about the existence of an approved vaccine against RSV for older adults. Those educated on vaccine approval process or about potential severity of RSV may be more accepting.
CDC gives full approval to RSV vaccine for people over 60
Jun 29, 2023
Those adults considered most at risk have chronic heart or lung disease, a weakened immune system or live in a long-term care facility.
CDC panel backs RSV vaccine for seniors
Jun 22, 2023
The panel called for “shared clinical decision-making” between doctors and patients and stopped short of recommending that all older adults get the shots.
FDA approves Pfizer RSV vaccine for older adults
Jun 01, 2023
The CDC is expected to meet later in the month to adopt vaccine recommendations for older Americans.
FDA approves first RSV vaccine
May 03, 2023
Arexvy was ~82% effective in preventing RSV-induced lower respiratory tract infections in adults aged 60 or more years.
RSVpreF safe, effective for preventing respiratory syncytial virus illness in seniors
Apr 10, 2023
The findings seen in phase 3 trial of adults aged 60 years and older receiving a single intramuscular injection of RSVpreF vaccine.
Pandemic disrupted respiratory syncytial virus season timing
Apr 07, 2023
However, evidence shows that the 2022 to 2023 season is a return toward prepandemic seasonality.
FDA panel backs second RSV vaccine for older Americans
Mar 02, 2023
In a two-part vote, the panel voted 10-to-2 in favor of the vaccine’s safety and unanimously on the shot’s effectiveness.
FDA panel backs Pfizer RSV vaccine for older Americans
Mar 01, 2023
Pfizer has reported that its vaccine would reduce risk from RSV by as much as 86%.
FDA approves first home test to detect both flu and COVID-19
Feb 27, 2023
The test will be sold without a prescription and can be used by anyone 14 years and older or by an adult on children ages 2 years and older.